Damora Therapeutics, Inc. (DMRA)
NASDAQ: DMRA · Real-Time Price · USD
24.23
-1.27 (-4.98%)
At close: Apr 28, 2026, 4:00 PM EDT
24.49
+0.26 (1.07%)
After-hours: Apr 28, 2026, 6:42 PM EDT
Damora Therapeutics Market Cap
Damora Therapeutics has a market cap or net worth of $1.46 billion as of April 28, 2026. Its market cap has increased by 49,672.74% in one year.
Market Cap
1.46B
Enterprise Value
1.20B
1-Year Change
49,672.74%
Ranking
Category
Stock Price
$24.23
Market Cap Chart
Since October 29, 2020, Damora Therapeutics's market cap has increased from $368.78M to $1.46B, an increase of 296.21%. That is a compound annual growth rate of 28.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 1.54B | 4,083.81% |
| Dec 31, 2025 | 36.75M | 500.17% |
| Dec 31, 2024 | 6.12M | -68.63% |
| Dec 29, 2023 | 19.52M | -33.64% |
| Dec 30, 2022 | 29.42M | -61.57% |
| Dec 31, 2021 | 76.54M | -75.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 29, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MBX Biosciences | 1.57B |
| Immatics | 1.54B |
| Ardelyx | 1.50B |
| Bicara Therapeutics | 1.49B |
| Agios Pharmaceuticals | 1.48B |
| Immunocore Holdings | 1.48B |
| Biohaven | 1.48B |
| Iovance Biotherapeutics | 1.46B |